The $300 million trial between Dakota Access Pipeline developer and Greenpeace reached the halfway mark on Monday as the company wrapped up its side of the case. Energy Transfer claims Greenpeace ...

The "Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025" report highlights significant R&D opportunities with over 20 companies and 22 pipeline drugs, focusing on innovative treatments like ...

If you have been paying any attention to Praxis Precision Medicines lately, you have probably noticed the ticker’s rollercoaster ride. Over the past week alone, shares have skyrocketed by an ...

Praxis Precision Medicines ( ($PRAX) ) just unveiled an announcement. On October 21, 2025, Praxis Precision Medicines updated its corporate ...

SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosisTopline data expected in ...

FMC-242 is a potentially best-in-class covalent allosteric inhibitor that breaks the interaction between PI3Kα and RAS, ...

Exclusive: UAE investment group in talks with ministries and private investors as it targets growth in Saudi Arabia’s ...

With over 17 years of experience across global technology leaders like Meta, Apple, Netgear, and Sierra Wireless, Prasad ...

Within this space, Mashael Alqahtani crafts stories that merge global resonance with personal nuance, using genre and comedy to explore the interplay of ...

Global Marine-Derived Oncology Drugs Market to Reach $1.75 Billion by 2025, Driven by Expanding Clinical Pipeline and Rising Cancer Burden  The global Marine-Derived Oncology Drugs Market is projected ...

Baystreet.ca News Commentary – Major biotechnology companies are presenting multi-cancer detection data and breakthrough clinical results at the European Society for Medical Oncology ...

SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc ...